CTRI/2020/04/024457已完成未知
A Study to Evaluate the Safety and Efficacy Of Female Intimate Wash Product in Maintaining a Healthy pH and Microflora in Healthy Indian Women.
ITC Life Sciences and Technology Centre0 个研究点目标入组 35 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy women in the age group of 18- 55 years.
- •2. Atleast one instance of UTI in the past 6
- •3. Women willing to abide by the study protocol
- •and study restrictions including abstinence from:
- •use of any other product besides the allotted
- •product during the study course, changing their usual brand of sanitary products and laundry detergents during the study course,showering/ bathing / cleaning their genitals with the test product on the day of study visit,depilation of pubic hair through topical products/waxing/ shaving (Trimming with scissors allowed)during the study course,oral or topical Anti-biotic/ Anti mycotic/Anti
- •inflammatory medicine or OTC / products without
- •informing to the study investigator.
排除标准
- •1. Women who are pregnant or lactating
- •2. Women with a known history or present condition of allergic response to any cosmetic products/ fragranced product which may influence the study result.
- •3. Women with bacterial vaginosis/ candidiasis/
- •mycotic infections / active psoriasis/ eczema/
- •other active skin disorder / any form of chronic infection / allergy / disease which may influence the study result.
- •4. Women in the post menopausal age group
- •5. Women with vulvo-vaginal dryness
- •6. Women who are currently taking or had taken
- •antibiotics course in the past 3 months
- •7. Women who have changed the contraceptive
- •medications or Menopausal / Hormonal treatment in the past 3 months or are contemplating to do so.
研究者
相似试验
已完成
4 期
A Pilot Study to Evaluate Efficacy and Safety of Fixed Dose Combination Capsules in Patients with GERD and Overlapping Symptoms of DyspepsiaCTRI/2020/09/027876Abbott India limited50
招募中
2 期
A observational study for safety and efficacy of Fulvestrant 500mg in postmenopausal patients with ER positive advanced or recurrent breast cancer after prior endocrine treatment. (SBCCSG-29)ocally advanced or metastatic breast cancerJPRN-UMIN000009110Saitama Breast Cancer Clinical Study Group(SBCCSG)100
已完成
Unknown
study on overall improvement of Skin ParametersCTRI/2023/06/054242Transformative Learning Solutions Pvt Ltd75
进行中(未招募)
1 期
A Study to Evaluate the Safety and efficacy of the Antibody APX005M in Adult Patients with Metastatic Melanoma Who have not Received Prior Immunotherapynresectable or metastatic melanomaMedDRA version: 20.0 Level: LLT Classification code 10027481 Term: Metastatic melanoma System Organ Class: 100000004864EUCTR2018-003864-30-ESApexigen, Inc.36
招募中
4 期
Real world study on the efficacy and safety of Shenqi Jiangtang tablets in the treatment of type 2 diabetes mellitusITMCTR2100004820People's Hospital of Wuhan University
